Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Replimune Group, Inc. | Chief Executive Officer, Director | Common Stock | 202K | $2.51M | $12.42 | Dec 16, 2024 | Direct |
Revolution Medicines, Inc. | Director | Common Stock | 19.9K | $1.08M | $54.14 | Oct 31, 2024 | Direct |
Replimune Group, Inc. | Chief Executive Officer, Director | Employee Stock Option (right to buy) | 250K | Apr 1, 2024 | Direct | ||
Revolution Medicines, Inc. | Director | Stock Option (Right to Buy) | 13.4K | Oct 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Dec 16, 2024 | 1 | -$124K | 4 | Dec 18, 2024 | Chief Executive Officer, Director |
RVMD | Revolution Medicines, Inc. | Oct 31, 2024 | 3 | -$147K | 4 | Nov 4, 2024 | Director |
RVMD | Revolution Medicines, Inc. | Jul 9, 2024 | 3 | -$58.6K | 4 | Jul 10, 2024 | Director |
RVMD | Revolution Medicines, Inc. | Jun 20, 2024 | 2 | $0 | 4/A | Jun 28, 2024 | Director |
RVMD | Revolution Medicines, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
REPL | Replimune Group, Inc. | May 16, 2024 | 1 | -$131K | 4 | May 20, 2024 | Chief Executive Officer, Director |
RVMD | Revolution Medicines, Inc. | Apr 10, 2024 | 3 | -$43.5K | 4 | Apr 12, 2024 | Director |
REPL | Replimune Group, Inc. | Apr 1, 2024 | 2 | $0 | 4 | Apr 3, 2024 | Chief Executive Officer, Director |
REPL | Replimune Group, Inc. | Jun 13, 2023 | 2 | -$137K | 4 | Jun 15, 2023 | Chief Strategy Officer |
RVMD | Revolution Medicines, Inc. | Jun 8, 2023 | 2 | $0 | 4 | Jun 12, 2023 | Director |
REPL | Replimune Group, Inc. | May 16, 2023 | 1 | -$281K | 4 | May 18, 2023 | Chief Strategy Officer |
REPL | Replimune Group, Inc. | Apr 1, 2023 | 2 | $0 | 4 | Apr 4, 2023 | Chief Strategy Officer |
RVMD | Revolution Medicines, Inc. | Jun 16, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
RVMD | Revolution Medicines, Inc. | Jun 16, 2022 | 0 | $0 | 3 | Jun 17, 2022 | Director |
REPL | Replimune Group, Inc. | May 16, 2022 | 1 | -$156K | 4 | May 18, 2022 | Chief Commercial Officer |
REPL | Replimune Group, Inc. | Apr 1, 2022 | 2 | $0 | 4 | Apr 5, 2022 | Chief Commercial Officer |